Literature DB >> 12748669

Mesial temporal sclerosis--a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity.

M Faraci1, E Lanino, S Dallorso, G Morreale, B Cappelli, R Gaggero, G Dini, R Haupt, M P Fondelli.   

Abstract

Mesial temporal sclerosis (MTS) is a common finding in patients with intractable temporal lobe epilepsy (TLE). In this report, we retrospectively reviewed the neuroimaging results of four children who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT), and who developed recurrent, partial, intractable seizures following a first event caused by cyclosporine-A (CSA) neurotoxicity. Neuroradiologic findings of MTS were demonstrated in all these patients. We suggest that MTS may be a consequence of CSA neurotoxicity, which induces repeated seizures, associated with other predisposing conditions, as well as being a consequence of the underlying disease and its treatment, and of severe graft-versus-host disease (GvHD).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748669     DOI: 10.1038/sj.bmt.1704023

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

1.  Mesial temporal sclerosis as a complication of hematologic cancer.

Authors:  Rafael Sivera; Luis Bataller; Jesús Martínez; Vicente Villanueva
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

2.  Chronic herpes simplex type-1 encephalitis with intractable epilepsy in an immunosuppressed patient.

Authors:  Christopher Laohathai; Daniel J Weber; Ghazala Hayat; Florian P Thomas
Journal:  Infection       Date:  2015-07-18       Impact factor: 3.553

3.  High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome.

Authors:  Anna Noè; Barbara Cappelli; Alessandra Biffi; Robert Chiesa; Ilaria Frugnoli; Erika Biral; Valentina Finizio; Cristina Baldoli; Paolo Vezzulli; Fabio Minicucci; Giovanna Fanelli; Rossana Fiori; Fabio Ciceri; Maria Grazia Roncarolo; Sarah Marktel
Journal:  Ital J Pediatr       Date:  2010-02-06       Impact factor: 2.638

Review 4.  Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.

Authors:  Gagandeep Singh; Jeremy H Rees; Josemir W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

Review 5.  Analysis of seizure risk factors after allogeneic hematopoietic stem cell transplantation: a 8 case report and literature review.

Authors:  Zhao-Dong Zhong; Lei Li; Yao-Hui Wu; Yong You; Wei-Ming Li; Ping Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

6.  Surgical treatment of refractory epilepsy after chemotherapy in two children with leukemia.

Authors:  Yun Leng; Tao Yu; Yongjie Li; Wenming Chen
Journal:  Epilepsy Behav Case Rep       Date:  2013-02-04

7.  Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: Case report in an adult and analysis of reported cases in the literature.

Authors:  Adam S Vesole; Yasunori Nagahama; Mark A Granner; Matthew A Howard; Hiroto Kawasaki; Brian J Dlouhy
Journal:  Epilepsy Behav Case Rep       Date:  2018-02-08

8.  Drug resistant epilepsy with mesial temporal sclerosis as possible late neurological complication in two AML survivors after stem cell transplantation.

Authors:  Kwan-Ming Karen Yam; Wing-Kwan Alex Leung; Xian-Lun Zhu; Lai-Wah Eva Fung
Journal:  Epilepsy Behav Case Rep       Date:  2018-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.